Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07729332) titled 'Switching to Oral Weight Management Pharmacotherapy to Prevent Weight Regain After GLP-1 Therapy Discontinuation' on July 22.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Massachusetts General Hospital

Condition: Obesity

Intervention: Drug: Phentermine Pill

Recruitment Status: Not recruiting

Phase: Phase 4

Date of First Enrollment: November 1, 2026

Target Sample Size: 60

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/study/NCT07729...